JP2007512381A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512381A5
JP2007512381A5 JP2006541869A JP2006541869A JP2007512381A5 JP 2007512381 A5 JP2007512381 A5 JP 2007512381A5 JP 2006541869 A JP2006541869 A JP 2006541869A JP 2006541869 A JP2006541869 A JP 2006541869A JP 2007512381 A5 JP2007512381 A5 JP 2007512381A5
Authority
JP
Japan
Prior art keywords
arthritis
medicament
combination
rheumatoid arthritis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512381A (ja
Filing date
Publication date
Priority claimed from GBGB0327840.5A external-priority patent/GB0327840D0/en
Application filed filed Critical
Publication of JP2007512381A publication Critical patent/JP2007512381A/ja
Publication of JP2007512381A5 publication Critical patent/JP2007512381A5/ja
Pending legal-status Critical Current

Links

JP2006541869A 2003-12-01 2004-11-30 医薬的組み合わせ Pending JP2007512381A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0327840.5A GB0327840D0 (en) 2003-12-01 2003-12-01 Organic compounds
PCT/EP2004/013587 WO2005053661A2 (en) 2003-12-01 2004-11-30 Pharmaceutical combinations

Publications (2)

Publication Number Publication Date
JP2007512381A JP2007512381A (ja) 2007-05-17
JP2007512381A5 true JP2007512381A5 (https=) 2008-01-24

Family

ID=29798110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541869A Pending JP2007512381A (ja) 2003-12-01 2004-11-30 医薬的組み合わせ

Country Status (11)

Country Link
US (1) US20070117833A1 (https=)
EP (1) EP1819361A2 (https=)
JP (1) JP2007512381A (https=)
KR (1) KR20060122877A (https=)
CN (1) CN1886157A (https=)
AU (1) AU2004294282B2 (https=)
BR (1) BRPI0417146A (https=)
CA (1) CA2546738A1 (https=)
GB (1) GB0327840D0 (https=)
RU (1) RU2006123312A (https=)
WO (1) WO2005053661A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4547911B2 (ja) 2002-02-01 2010-09-22 アリアド・ファーマシューティカルズ・インコーポレイテッド リン含有化合物およびその用途
WO2006053754A1 (en) * 2004-11-19 2006-05-26 Novartis Ag COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE
CA2629714A1 (en) * 2005-11-14 2007-05-24 Ariad Gene Therapeutics, Inc. Administration of an mtor inhibitor to treat patients with cancer
AU2007204410A1 (en) * 2006-01-12 2007-07-19 Novartis Ag Combination of mTOR inhibitor and antipolate compound
EP1880723A1 (en) * 2006-07-14 2008-01-23 Novartis AG Combination of mTOR inhibitor and antifolate compound
LT1983984T (lt) * 2006-02-02 2018-06-11 Novartis Ag Tuberozinės sklerozės gydymas
US20090023768A1 (en) * 2006-02-24 2009-01-22 Novartis Ag Rapamycin derivatives for treating neuroblastoma
CN103330694A (zh) 2006-11-14 2013-10-02 阿里亚德医药股份有限公司 口服制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5258389A (en) * 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
EP0833828B1 (en) * 1995-06-09 2002-11-20 Novartis AG Rapamycin derivatives
GB0123025D0 (en) * 2001-09-25 2001-11-14 Eirx Therapeutics Ltd Apoptosis
TW200306826A (en) * 2002-01-10 2003-12-01 Novartis Ag Drug delivery systems for the prevention and treatment of vascular diseases
JP4547911B2 (ja) * 2002-02-01 2010-09-22 アリアド・ファーマシューティカルズ・インコーポレイテッド リン含有化合物およびその用途
AU2003247483A1 (en) * 2002-05-30 2003-12-31 The Children's Hospital Of Philadelphia Methods for treatment of acute lymphocytic leukemia
JP2006517969A (ja) * 2003-02-14 2006-08-03 コンビナトアールエックス インコーポレーティッド 免疫炎症性障害の治療のための組み合わせ療法

Similar Documents

Publication Publication Date Title
US10561618B2 (en) Orally available pharmaceutical formulation suitable for improved management of movement disorders
JP5796959B2 (ja) 関節炎における痛みの治療のためのタペンタドール
JP2000507544A (ja) 痛みの治療方法
WO2016062283A1 (zh) 抗发炎用药物在制备抑制癌症的医药组合物中的应用
JP2013521304A5 (https=)
JP2008539250A (ja) アテローム性動脈硬化症を処置するための方法
JP2007512381A5 (https=)
JP2020519576A5 (https=)
WO2014199294A1 (en) Pharmaceutical combinations of a pi3k inhibitor and a microtubule destabilizing agent
JP2016505050A5 (https=)
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
US10576076B2 (en) Pharmaceutical combination of everolimus with dactolisib
HRP20251043T1 (hr) Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća
Kumar et al. Cilostazol: a new drug in the treatment intermittent claudication
US20110269755A1 (en) Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
AU2007234917B2 (en) Renin inhibitors for the treatment of hypertension
EP3789020A1 (en) Fixed dose composition of paracetamol: amitriptyline and method for the treatment of mixed cancer pain
JP2008527034A5 (https=)
MY207573A (en) Combination of ibuprofen and tramadol for relieving pain
JP2006076945A (ja) 線維筋痛症候群の治療剤
WO2017017511A1 (en) Modified release formulation for treating premature ejaculation
JP2004244347A (ja) イトラコナゾール併用剤
HK1207285B (en) Orally available pharmaceutical formulation suitable for improved management of movement disorders
BRPI0503488A (pt) agente de tratamento para sìndrome de intestino irritável com diarréia predominante
WO2011000563A4 (en) Eltoprazine for the treatment of weight disorders